U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H20Br2N2
Molecular Weight 376.13
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BROMHEXINE

SMILES

CN(CC1=C(N)C(Br)=CC(Br)=C1)C2CCCCC2

InChI

InChIKey=OJGDCBLYJGHCIH-UHFFFAOYSA-N
InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3

HIDE SMILES / InChI

Molecular Formula C14H20Br2N2
Molecular Weight 376.13
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:20:48 UTC 2023
Edited
by admin
on Fri Dec 15 15:20:48 UTC 2023
Record UNII
Q1J152VB1P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BROMHEXINE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
BROMHEXINE [MI]
Common Name English
BROMHEXINE [MART.]
Common Name English
bromhexine [INN]
Common Name English
Bromhexine [WHO-DD]
Common Name English
BENZENEMETHANAMINE, 2-AMINO-3,5-DIBROMO-N-CYCLOHEXYL-N-METHYL-
Systematic Name English
FLUIBRON
Brand Name English
Classification Tree Code System Code
WHO-ATC R05CB02
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
LIVERTOX 122
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
WHO-VATC QR05CB02
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
FDA ORPHAN DRUG 34789
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL253376
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
DRUG BANK
DB09019
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
FDA UNII
Q1J152VB1P
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
SMS_ID
100000088676
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
NCI_THESAURUS
C172826
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
MERCK INDEX
m2668
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY Merck Index
DRUG CENTRAL
402
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
CAS
3572-43-8
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
ECHA (EC/EINECS)
222-684-1
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
CHEBI
77032
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
EPA CompTox
DTXSID6022686
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
MESH
D001964
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
WIKIPEDIA
BROMHEXINE
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
EVMPD
SUB05914MIG
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
PUBCHEM
2442
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
RXCUI
1753
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY RxNorm
DAILYMED
Q1J152VB1P
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
INN
2584
Created by admin on Fri Dec 15 15:20:48 UTC 2023 , Edited by admin on Fri Dec 15 15:20:48 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Activation of TMPRSS2 plays an important role in viral respiratory diseases such as influenza A and Middle East Respiratory Syndrome (MERS). Inhibition of receptor activation and viral entry by bromhexine may be effective in preventing or treating various respiratory illnesses, including COVID-19.5 In vitro studies have suggested the action of ambroxol (a metabolite of bromhexine) on the angiogensin-converting enzyme receptor 2 (ACE2), prevents entry of the viral envelope-anchored spike glycoprotein of SARS-Cov-2 into alveolar cells or increases the secretion of surfactant, preventing viral entry.
IC50
BINDER->LIGAND
SALT/SOLVATE -> PARENT
Related Record Type Details
METABOLITE ACTIVE -> PARENT
When bromhexine is administered orally, the systemic exposure to ambroxol is much lower (;8-fold; Liu et al., 2010), but since the true molecular action of these agents is not entirely known, it cannot be ascertained whether bromhexine or ambroxol, or both, contribute to activity. Ambroxol has also been associated with a reduction in throat pain, which has triggered investigation into the activity of it and bromhexine at sodium channels (such as NaV1.8 and the tetrodotoxin sensitive channel; Leffler et al., 2010).
MAJOR
PLASMA
METABOLITE -> PARENT
MINOR
PLASMA
METABOLITE -> PARENT
MAJOR
PLASMA
METABOLITE -> PARENT
MINOR
PLASMA
Related Record Type Details
ACTIVE MOIETY